TLDR Botulinum toxin injections greatly reduced pain in Parry-Romberg syndrome.
Parry-Romberg syndrome, a rare condition marked by progressive hemifacial atrophy, hair loss, and retinal vasculopathy, was treated in a case study with repetitive botulinum type A toxin injections. This treatment led to an almost complete resolution of severe chronic pain associated with the syndrome. The study highlighted the potential role of vasculopathy in the development of neurologic damage and facial lipodystrophy in Parry-Romberg syndrome.
26 citations
,
April 2006 in “Cephalalgia” Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.
10 citations
,
February 2015 in “Clinics in Dermatology” The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.
January 2017 in “Springer eBooks” The document explains various skin conditions and their treatments.
43 citations
,
June 2016 in “Clinics in Plastic Surgery” The conclusion is that fat grafting is safe and effective but carries risks that need careful management.
387 citations
,
May 2019 in “International Journal of Molecular Sciences” Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.
May 2015 in “Journal of The American Academy of Dermatology” A woman with Parry-Romberg syndrome developed new curly hair on one side of her scalp, a condition not previously linked to the syndrome.
